investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF

M. James You

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Reuben Kapur

Role of p21 Activated Kinase in Leukemogenesis

Leukaemia

Hematology and hematologic malignancies

Vinay Pathak

Retroviral Replication and Interactions with Host Factors

Leukaemia

Pathology Hematology and hematologic malignancies

Daniel McVicar

Characterization of the Expression and Ligands of KIR3DS2

Leukaemia

Pathology Hematology and hematologic malignancies

Effie W Petersdorf

Clinical Significance of MHC Haplotypes in HCT

Leukaemia

Peter Aplan

Collaborative Pathways that Lead to Leukemia – Rockville

Leukaemia

Pathology Hematology and hematologic malignancies

Markus Muschen

Negative Feedback Signaling in Tyrosine Kinase-Driven Leukemia

Leukaemia

Mary V. Relling

Center for Precision Medicine in Leukemia (CPML)

Leukaemia

Pathology

William E. Evans

Pharmacogenomics of Childhood Leukemia ALL

Leukaemia

Pediatric oncology or childhood cancer

Carol Prives

Properties and Regulation of p53 in Tumor Cells

Leukaemia

Pathology